mefloquine has been researched along with artesunic acid in 266 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.38) | 18.7374 |
| 1990's | 31 (11.65) | 18.2507 |
| 2000's | 102 (38.35) | 29.6817 |
| 2010's | 114 (42.86) | 24.3611 |
| 2020's | 18 (6.77) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, K; Canfield, C; Charoenlarp, P; Kyle, D; Looareesuwan, S; Suntharasamai, P; Vanijanonta, S; Viravan, C; Webster, K; Wilairatana, P | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Webster, HK; Wilairatana, P | 1 |
| Than, M; Thwe, Y; Win, K | 1 |
| Li, GD | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Raimond, SD; White, NJ | 1 |
| Andrial, M; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Graninger, W; Looareesuwan, S; Presterl, E; Wenisch, C | 1 |
| Chongsuphajaisiddhi, T; Eh, JP; Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ; Woodrow, C | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Nosten, F | 1 |
| Andrial, M; Charoenlarp, P; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Back, DJ; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K; Thanavibul, A | 1 |
| Canfield, C; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Andrial, M; Looareesuwan, S; Pitisuttithum, P; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Burgmann, H; Graninger, W; Looareesuwan, S; Vanijanonta, S; Viravan, C; Vorbach, H; Zedwitz-Liebenstein, K | 1 |
| Heppner, DG; Kawamoto, F; Nguyen, TD; Sookto, P; Trieu, NT; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
| Andrial, M; Chalermrut, K; Looareesuwan, S; Molunto, W; Olliaro, P; Wilairatana, P | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Chanyakhun, P; Palananth, C; Rooney, W; Sirichaisinthop, J; Thimasarn, K | 1 |
| Chongsuphajaisiddhi, T; Looareesuwan, S; Viriyavejakul, P; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Kanda, T; Karbwang, J; Pungpak, S; Thimasarn, K | 1 |
| Chung, SY; Das, R; Oon, CT | 1 |
| Aung, S; Lwin, M; Shwe, T | 1 |
| Chongsuphajaisiddhi, T; Heppner, DG; Luxemburger, C; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; Than, MM; White, NJ | 1 |
| Chongsuphajaisiddhi, T; Kham, A; Luxemburger, C; McGready, R; Nosten, F; Phaipun, L; Price, R; Simpson, J; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Hills, F; Krudsood, S; Looareesuwan, S; Porter, RS; Sjostrom, L; Warrell, DA; Wilairatana, P | 1 |
| Aursudkij, B; Gordeux, VR; Looareesuwan, S; Vannaphan, S; Walsh, DS; Wilairatana, P | 1 |
| Aarons, L; Chongsuphajaisiddhi, T; Looareesuwan, S; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; ter Kuile, F; White, NJ | 1 |
| Burgmann, H; Chullawichit, S; Daxböck, F; El-Menyawi, I; Graninger, W; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
| Angus, BJ; Htoo, SE; Looareesuwan, S; Mann, C; Nosten, F; Poletto, C; Price, RN; Simpson, JA; Van Vugt, M; White, NJ | 1 |
| Bussaratid, V; Chokejindachai, W; Hendriksen, C; Krudsood, S; Looareesuwan, S; Scheiwe, MW; Silachamroon, U; Viriyavejakul, P; Wilairatana, P | 1 |
| Aung, S; Lwin, M; Mar, KK; Shwe, T; Win, LL; Zaw, AK | 1 |
| Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Brockman, A; Looareesuwan, S; Luxemburger, C; McGready, R; Nosten, F; Price, R; ter Kuile, F; Thway, KL; van Vugt, M; White, NJ | 1 |
| Bloland, PB; Ettling, M; Meek, S | 1 |
| Ambroise-Thomas, P | 1 |
| Rozendaal, J | 1 |
| Congpuong, K; Karwacki, JJ; Miller, RS; Pang, L; Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Bounyasong, S | 1 |
| Ginsburg, H; Hoshen, MB; Stein, WD | 1 |
| Belsare, H; Patel, AB | 1 |
| Cambon, N; Chalermrut, K; Krudsood, S; Looareesuwan, S; Mueller, EA; Pittrow, D; Silachamroon, U | 1 |
| Dyk Dao, L; Rabinovich, SA; Van Ha, N | 1 |
| Hijar, G; Kain, KC; Marouiño, W; Montoya, Y; Pillai, DR; Ruebush, TK; Wongsrichanalai, C | 1 |
| Gao, BH; Huang, KG; Yang, HL | 1 |
| Faiz, MA; Hossain, MA; Miller, RS; Noedl, H; Pang, LW; Rahman, MR; Samad, R; Wongsrichanalai, C; Yunus, EB | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Chalermrut, K; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Chaikachonpatd, S; Chanthapakajee, K; Chindarat, S; Kaewkaukul, N; Lim, K; Silpasakorn, S; Suputtamongkol, Y; Thamlikitkul, V | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Chen, RJ; Fu, LC; Guo, WZ; Guo, XB; Ou, FZ; Tan, B; Zheng, QJ | 1 |
| Cambon, N; Gomez, EA; Jurado, MH | 1 |
| Hoshen, M | 1 |
| Brockman, A; Katterman, N; Kyaw, MK; Lwin, S; Smithuis, F; van der Broek, I; White, NJ | 1 |
| Avila, JC; Marquiño, W; Mollinedo, R; Ruebush, TK; Villaroel, R; Zegarra, J | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Bunnag, D; Chittamas, S; Kanda, T; Looareesuwan, S; Pornkulprasit, V; Rojanawatsirivej, C; Thimasarn, K; Wattanakoon, Y | 1 |
| Chim, P; Fandeur, T; Lim, P; Maciejewski, L; Nhem, S; Sem, R | 1 |
| Majori, G | 1 |
| Binh, TQ; de Vries, PJ; Giao, PT; Holman, R; Hung, le Q; Kager, PA; Nam, NV | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Krudsood, S; Leowattana, W; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Srivilairit, S; White, NJ; Wilairatana, P | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Chim, P; Denis, MB; Fandeur, T; Lim, C; Lim, P; Nemh, S; Poravuth, Y; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Day, NP; Dondorp, AM; Farrar, JJ; Green, MD; Hien, TT; Johnson, A; Looareesuwan, S; Lynam, AJ; Mayxay, M; McGready, R; Newton, PN; Petit, A; Smithuis, FM; Van Damme, W; White, NJ; Yeung, S | 1 |
| Pilz, JB; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, G | 1 |
| Bangchang, KN; Congpuong, K; Rojanawatsirivet, C; Thongphua, S; Thongsri, K; Vijaykadga, S; Wernsdorfer, WH; Wilairatana, P | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI | 1 |
| Chanthap, L; Na-Bangchang, K; Nivanna, N; Socheat, D; Sovannarith, T; Suksom, D; Tsuyuoka, R | 1 |
| Ashley, EA; Barends, M; Hutagalung, R; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Proux, S; Slight, T; Thwai, KL; White, NJ | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Chalermrut, K; Krudsood, S; Leowattana, W; Looareesuwan, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Thimasarn, K; Wilaiaratana, P | 1 |
| Attanath, P; Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P; Wongsuwan, A | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Binh, VQ; Dai, B; Dao, NV; Edstein, MD; Ngoa, ND; Quoc, NP; Rieckmann, KH; The, ND; Thuy, le T | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| Bukirwa, H; Orton, L | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Phongtananant, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Wilairatana, P | 1 |
| Chang, SC; Chen, YC; Fang, CT; Kuo, PH; Sun, HY; Wang, JT | 1 |
| Cholpol, S; Nakavej, A; Phoungmanee, D; Rojanawatsirivej, C; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Counillon, E; Del Giudice, P; Delaunay, P; Vandenbos, F | 1 |
| Ashley, EA; Brockman, A; Carrara, VI; Gilbos, V; Krudsood, S; Leemingsawat, S; Looareesuwan, S; McGready, R; Nosten, F; Proux, S; Rojanawatsirivet, C; Singhasivanon, P; Sirilak, S; Thonglairuam, J; White, N | 1 |
| Duffy, PE; Mutabingwa, TK | 1 |
| Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
| Ashley, EA; Hae, R; Hutagalung, R; Lindegårdh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Rees, PH | 1 |
| Bhatt, KM; Bhatt, SM; Samia, BM; Wasunna, KM | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Christophel, EM; Denis, MB; Incardona, S; Lim, C; Lim, P; Narann, TS; Poravuth, Y; Ringwald, P; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Ashley, EA; Barends, M; Leowattana, W; Lwin, KM; McGready, R; Nawamaneerat, W; Nosten, F; Olliaro, P; Phaiphun, L; Proux, S; Simon, WH; Singhasivanon, P; Stepniewska, K; Taylor, W; Thwai, KL; Wangseang, N; White, NJ | 1 |
| Annerberg, A; Christophel, EM; Denis, MB; Fandeur, T; Lim, P; Lindegardh, N; Ringwald, P; Socheat, D; Top, SN; Tsuyuoka, R; Yi, P | 1 |
| Ashley, E; Carrara, V; McGready, R; Nosten, F; Price, R; Singhasivanon, P | 1 |
| Cambon, N; Davis, TM; Dunlop, AM; England, M; Heidecker, JL; Ilett, KF; Keller, TG; Page-Sharp, M | 1 |
| Brockman, A; Chotivanich, K; Day, NP; Stepniewska, K; White, NJ | 1 |
| Anderson, T; Barends, M; Brockman, A; Jaidee, A; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; White, NJ | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Alker, AP; Ariey, F; Bouth, DM; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Sem, R; Shah, NK; Tsuyuoka, R; Wongsrichanalai, C; Yi, P | 1 |
| Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P | 1 |
| Abuaku, B; Duah, NO; Koram, KA; Quashie, NB | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Lai, CS; Mansor, SM; Nair, NK; Navaratnam, V; Olliaro, PL | 1 |
| Adegnika, AA; Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Cambon, N; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, FM; Mamfoumbi, MM; Missinou, MA; Ramharter, M | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Bernasconi, A; Casapia, M; D'Alessandro, U; Delgado, C; Erhart, A; Fanello, C; Gamboa, D; Grande, T; Llanos-Cuentas, A; Torres, K | 1 |
| Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
| Ashley, EA; Lwin, KM; McGready, R; Nosten, F; Proux, S; Silamut, K | 1 |
| Zarocostas, J | 1 |
| Chonsawat, P; Kano, S; Krudsood, S; Phophak, N; Srivilairit, S; Tangpukdee, N; Wilairatana, P; Yanpanich, W | 1 |
| Brittenham, GM; Kano, S; Krudsood, S; Li, G; Looareesuwan, S; Pengruksa, C; Phophak, N; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Beck, HP; Borrmann, S; Genton, B; Hodel, EM; Marfurt, J; Müller, D; Müller, I; Reeder, JC; Rippert, A; Siba, P | 1 |
| Andrade, AA; Boechat, N; Botelho, AC; de Paula, RC; de Pilla Varotti, F; de Souza, MV; Fagundes, EM; Krettli, AU; Mayer, LM; Mendonça, JS; Valverde, A | 1 |
| Agomo, PU; Aina, OO; Ezeiru, VI; Meremikwu, MM; Odey, FA; Oguche, S; Omalu, IJ; Watila, IM | 1 |
| Alker, AP; Ariey, F; Duong, S; Maguire, JD; Meshnick, SR; Muth, S; Sem, R; Shah, NK; Susanti, AI; Wongsrichanalai, C | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Arunkamomkiri, J; Carrara, VI; Htoo, H; Nosten, F; Nwee, P; Phyo, AP; Singhasivanon, P; Soe, M | 1 |
| Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
| Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
| Alker, AP; Ariey, F; Bouchier, C; Bouth, DM; Doung, S; Fandeur, T; Incardona, S; Khim, N; Le Bras, J; Lim, P; Meshnick, SR; Puijalon, OM; Ringwald, P; Shah, NK; Wongsrichanalai, C; Yi, P | 1 |
| Anderson, T; Ashley, EA; Barends, M; Brockman, A; Carrara, VI; Hutagalung, R; Imwong, M; Lwin, KM; McGready, R; Nosten, F; Phaiphun, L; Phyo, AP; Preechapornkul, P; Price, RN; Proux, S; Pukrittayakamee, S; Singhasivanon, P; Stepniewska, K; van Vugt, M; White, NJ; Zwang, J | 1 |
| Bacon, DJ; Durand, S; Ganguly, B; Green, M; Gutman, J; Quezada, WM; Rojas, OV; Ruebush, TK; Slutsker, L; Utz, GC | 1 |
| Chaijaroenkul, W; Harnyuttanakorn, P; Mungthin, M; Na Bangchang, K; Suwandittakul, N | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| An, SS; Ariey, F; Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Herdman, T; Imwong, M; Lee, SJ; Lim, P; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Singhasivanon, P; Socheat, D; Tarning, J; White, NJ; Yeung, S; Yi, P | 1 |
| Ambler, MT; Arunjerdja, R; Dubowitz, LM; Hla, EP; Luxemburger, C; McGready, R; Nosten, F; Singhasivanon, P; Thwai, KL; Viladpainguen, J | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Wisedpanichkij, R | 1 |
| Balogun, S; Folarin, O; Gbotosho, GO; Happi, C; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Adewoye, EO; Gbotosho, GO; Happi, CT; Nkogho, OO; Okuboyejo, TM; Sowunmi, A | 1 |
| Alvarez, LG; Blair, S; Ríos, A; Sanín, F; Tobón, A; Vásquez, AM | 1 |
| Ariey, F; Beck, HP; Bouth, DM; Chim, P; Chy, S; Coppee, JY; Duong, S; Fandeur, T; Genton, B; Gobert, JG; Khim, N; Kim, S; Le Bras, J; Lim, P; Mercereau-Puijalon, O; Nhem, S; Ringwald, P; Rogers, WO; Sem, R; Wongsrichanalai, C; Yi, P | 1 |
| Adoubryn, KD; Hatz, C; Keiser, J; N'Goran, EK; N'Guessan, NA; Silué, KD; Utzinger, J; Vounatsou, P | 1 |
| Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, F; Mamfoumbi, MM; Mihindou, MP; Missinou, MA; Ngoungou, EB; Ramharter, M; Trapp, S | 1 |
| Alam, MT; Ariey, F; Barnwell, JW; Escalante, AA; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Muth, S; Rogers, WO; Sem, R; Shah, NK; Susanti, AI; Udhayakumar, V; Vinayak, S; Wongsrichanalai, C | 1 |
| Biswas, B; Ghosh, A; Mallick, D; Thapa, R | 1 |
| Chelo, D; Djoukoue, FM; Frentzel, A; Frey, S; Hatz, C; Mina Ntoto, NK; Mueller, EA; Tietche, F; Trapp, S; Zielonka, R | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Phumratanaprapin, W; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatana, P | 1 |
| Han, SC; Heger, T; Husums, H; Larsen, S; Sundet, M; Van Heng, Y | 1 |
| Duangdee, C; Krudsood, S; Looareesuwan, S; Pothipak, N; Tangpukdee, N; Warrell, DA; Wilairatana, P | 1 |
| Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
| Fatunmbi, B; Folarin, O; Gbotosho, GO; Happi, CT; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Bacchieri, A; Bhattacharya, PC; Corsi, M; Dev, V; Dubhashi, N; Duparc, S; Ghosh, SK; Keomany, S; Khanthavong, M; Krudsood, S; Kumar, A; Mayxay, M; Newton, PN; Phyo, AP; Pongvongsa, T; Pukittayakamee, S; Pukrittayakamee, S; Rao, BH; Ruangveerayuth, R; Ubben, D; Uthaisil, C; Valecha, N | 1 |
| Jiao, PY; Mei, JY; Xiao, SH | 1 |
| Chaijaroenkul, W; Mahamad, P; Na-Bangchang, K; Ruengweerayut, K; Ruengweerayut, R | 1 |
| Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P | 1 |
| Akkhavong, K; Hatz, C; Keiser, J; Odermatt, P; Sayasone, S; Soukhathammavong, P; Vonghachack, Y; Vounatsou, P | 1 |
| Keola, S; Keomany, S; Khanthavong, M; Khomthilath, T; Mayxay, M; Newton, PN; Phompida, S; Pongvongsa, T; Souvannasing, P; Stepniewska, K; Ubben, D; Valecha, N; White, NJ | 1 |
| Berenger, AA; Didier, YJ; Djerea, K; Genevieve, GO; Kouame, MG; Penali, LK; Toure, OA | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatama, P | 1 |
| Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Braissant, O; Haggenmüller, Y; Keiser, J; Manneck, T | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Na-Bangchang, K; Ruengweerayut, R; Wernsdorfer, WH | 1 |
| Chaijaroenkul, W; Maensathian, T; Muhamad, P; Na-Bangchang, K; Phompradit, P; Rueangweerayut, R; Sornjai, W | 1 |
| Gil, JP; Piedade, R | 1 |
| Brooms, JD; Cruz, L; España, R; Giron, A; Magris, M; Metzger, WG; Peña Pimentel, FN; Perez, L; Villalobos, N; Vivas-Martínez, S | 1 |
| Barón, C; Carrasquilla, G; Cousin, M; Fisher, LM; Lefèvre, G; Monsell, EM; Sander, O; Walter, V | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Gbotosho, GO; Happi, CT; Lawal, O; Oduola, A; Sijuade, A; Sowunmi, A | 1 |
| Abdulla, S; Binh, TQ; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Pénali, LK; Phyo, AP; Poravuth, Y; Rueangweerayut, R; Shin, CS; Tien, NT; Tinto, H; Uthaisin, C; Valecha, N | 1 |
| Anvikar, AR; Bhatt, RM; Dash, AP; Ghosh, SK; Kumar, A; Mohanty, SS; Pillai, CR; Sharma, B; Sharma, SK; Valecha, N | 1 |
| Bacchieri, A; Bhattacharyya, PC; Corsi, M; Dev, V; Dubashi, N; Gargano, N; Ghosh, SK; Kumar, A; Rao, BH; Srivastava, B; Tommasini, S; Ubben, D; Valecha, N | 1 |
| Boulos, M; Daher, A; dos Santos, RL; Junger, W; Ladislau, JL; Leon, AP; Lucena, MB; Magalhães, I; Marchesini, PB; Ribeiro, I; Santelli, AC | 1 |
| Alker, AP; MacArthur, JR; Meshnick, SR; Satimai, W; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Delacollette, C; Kaewkungwal, J; Khamsiriwatchara, A; Lawpoolsri, S; Potithavoranan, T; Sangvichean, A; Satimai, W; Sawang, S; Singhasivanon, P; Sudathip, P; Vijaykadga, S | 1 |
| Charman, SA; Gamo-Benito, J; Humberstone, A; Jamsen, KM; McCaw, J; Moehrle, J; Price, RN; Simpson, JA; Smith, K; Zaloumis, S | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Boareto, AC; Dalsenter, PR; de Araujo, SL; Gomes, C; Lombardi, N; Lourenço, AC; Lourenço, EL; Minatovicz, B; Müller, JC; Paumgartten, FR | 1 |
| Holtermann, MK | 1 |
| Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM | 1 |
| Abiola, A; Ba, MC; Faye, B; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, M; Sow, D; Sylla, K; Tine, RC | 1 |
| Beeson, JG; Goodman, CD; Langer, C; McFadden, GI; Wilson, DW | 1 |
| Boareto, AC; Dalsenter, PR; de Morais, RN; Lombardi, N; Lourenço, AC; Lourenço, EL; Müller, JC; Rabitto, I; Rios, FS | 1 |
| Diap, G; Kiechel, JR; Wells, S | 1 |
| Ashley, E; Boel, M; Carrara, VI; Chu, C; Lwin, KM; McGready, R; Nosten, F; Phyo, AP; Proux, S; Rijken, M; Singhasivanon, P; Sriprawat, K; White, N; Wiladphaingern, J | 1 |
| Anderson, TJ; Jamsen, KM; Nair, S; Nosten, F; Price, RN; Simpson, JA; White, NJ; Woodrow, C; Zaloumis, S | 1 |
| Chaijaroenkul, W; Karbwang, J; Muhamad, P; Na-Bangchang, K; Ruaengweerayut, R | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Ariey, F; Duong, S; Kiechel, JR; Leang, R; Lim, P; Ménard, D; Navaratnam, V; Ros, S; Taylor, WR | 1 |
| Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Choi, AR; Kim, JH; Kim, YK; Yoon, S | 1 |
| Chaijaroenkul, W; Muhamad, P; Na-Bangchang, K; Phompradit, P; Wisedpanichkij, R | 1 |
| Krudsood, S; Tangpukdee, N; Wilairatana, P | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Adhikari, B; Krudsood, S; Tangpukdee, N; Wilairatana, P | 1 |
| Anvikar, AR; Dash, AP; Dubhashi, NG; Ghosh, SK; Jullien, V; Kiechel, JR; Kumar, A; Rao, BH; Sharma, B; Singh, JP; Srivastava, B; Taylor, WR; Valecha, N | 1 |
| Aguiar, AC; Amaral, NS; De Marco, L; Krettli, AU; Pereira, DB | 1 |
| Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
| Kameda, K | 1 |
| Abdali, N; Malik, AM; Rizvi, SW; Shamim, MD | 1 |
| Jullien, V; Kiechel, JR; Sharma, B; Srivastava, B; Valecha, N | 1 |
| Chotivanich, K; Chu, CS; McGready, R; Nosten, F; Tun, NW; White, NJ; Wongsaen, K | 1 |
| D'Alessandro, U; Davies, GR; Lindegardh, N; Tarning, J; Tinto, H; Toe, LC; Traore-Coulibaly, M; Valea, I; Van Geertruyden, JP; Ward, SA | 1 |
| Cheoymang, A; Muhamad, P; Na-Bangchang, K; Phompradit, P | 1 |
| Chaijaroenkul, W; Muhamad, P; Na-Bangchang, K; Phompradit, P | 2 |
| Adiossan, LK; Keiser, J; Monsan, N; N'Goran, EK; N'Guessan, NA; Silué, KD; Utzinger, J | 1 |
| Kramer, CV; Olliaro, PL; Sinclair, D; Zhang, F | 1 |
| Chaijaroenkul, W; Mubaraki, MA; Na-Bangchang, K; Ward, SA | 1 |
| Arboleda, M; Blair, S; Fernández, D; Garavito, G; Pabón, A; Segura, C | 1 |
| Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; Menon, J; Price, RN; Rajahram, G; von Seidlein, L; William, T; Yeo, TW | 1 |
| Evans, AM; Navaratnam, V; Olliaro, PL; Reuter, SE; Upton, RN | 1 |
| Changpradub, D; Mungthin, M | 1 |
| Claeys, Y; D'Alessandro, U; De Crop, M; Halidou, T; Kalanda, G; Menten, J; Mulenga, M; Mutabingwa, T; Mwakazanga, D; Mwapasa, V; Nambozi, M; Phiri, LK; Ravinetto, R; Schurmans, C; Tagbor, H; Thriemer, K; Traore, M; Valea, I; Van Geertruyden, JP | 1 |
| Chaijaroenkul, W; Na-Bangchang, K | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Cressey, TR; Kongjam, P; Na-Bangchang, K; Rattanapunya, S; Rueangweerayut, R; Tawon, Y | 1 |
| Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
| Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
| Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; McCarthy, JS; Menon, J; Pasay, C; Price, RN; Rajahram, GS; von Seidlein, L; Wilkes, CS; William, T; Yeo, TW | 1 |
| Anto, F; Ayanful-Torgby, R; Dery, V; Duah, NO; Matrevi, SA; Quashie, NB | 1 |
| Almela, MJ; Boechat, N; Herreros, E; Krettli, AU; Miguel-Blanco, C; Penna-Coutinho, J; Sá, PM | 1 |
| de Oliveira Vilhena, R; de Souza Madeira, CR; Marson, BM; Piantavini, MS; Pontarolo, R; Pontes, FL | 1 |
| Baird, JK; Boni, MF; White, NJ | 1 |
| Bastos, MS; de Melo, GN; de Souza-Lima, Rde C; Ferreira, MU; Ladeia-Andrade, S; Luz, Fd; Rodrigues, PT; Salla, LC | 1 |
| Roberts, L | 1 |
| Anstey, NM; Auburn, S; Barber, BE; Edstein, MD; Grigg, MJ; Menon, J; Price, RN; Rajahram, GS; Wilkes, CS; William, T; Yeo, TW | 1 |
| Amalvict, R; Benoit, N; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
| Eziefula, AC | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Muhamad, P; Na-Bangchang, K; Phompradit, P; Thiengsusuk, A | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO | 1 |
| Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
| Buyze, J; D'Alessandro, U; Hachizovu, S; Kabuya, JB; Kasongo, W; Mulenga, J; Mulenga, M; Mwakazanga, D; Nambozi, M; Van Geertruyden, JP | 1 |
| Barboza, TMT; Chaves, GC; Gonçalves, LPB; Luiza, VL; Stobbaerts, EG | 1 |
| Akter, J; Aogo, RA; Best, SE; Cromer, D; Davenport, MP; Elliott, T; Engel, JA; Gartlan, KH; Haque, A; James, KR; Khoury, DS; Sebina, I; Soon, MSF; Thomas, BS | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Phompradit, P | 1 |
| Anvikar, AR; Arya, T; Bruce, J; Chandramohan, D; Greenwood, B; Kuepfer, I; Mishra, DR; Mishra, N; Mishra, V; Mohanty, R; Mohanty, S; Sharma, S; Srivastava, B; Valecha, N | 1 |
| Akter, J; Aogo, RA; Cromer, D; Davenport, MP; Elliott, T; Fogg, LG; Haque, A; Khoury, DS; Laohamonthonkul, P; Liligeto, UN; Nair, AS; Pernold, CPS; Romanczuk, AS; Soon, MSF; Thomas, BS | 1 |
| Hoglund, RM; Na-Bangchang, K; Ruengweerayut, R | 1 |
| Cao, P; Cromer, D; Davenport, MP; Dini, S; Fowkes, FJI; Khoury, DS; McCaw, JM; Simpson, JA; Zaloumis, SG | 1 |
| Aydin-Schmidt, B; Björkman, A; Di Santi, S; Inoue, J; Islam, A; Jovel, I; Mårtensson, A; Morris, U; Segurado, AC | 1 |
| Hine, P; Pryce, J | 1 |
| Buffet, P; Chambrion, C; Chartrel, N; Mouri, O; Ndour, PA; Roussel, C; Smith, B; Smith, P; Thellier, M; Wojnarski, M | 1 |
| Aouri, M; Carn, G; Csajka, C; Decosterd, LA; Guidi, M; Kiechel, JR; Mercier, T; Ogutu, B | 1 |
| Andreotti, CEL; Antiquera Ferreira, F; Boechat, N; da Silva, GR; Dalsenter, PR; de Lima, DA; Gasparotto Junior, A; Lívero, FADR; Lourenço, ELB; Pauli, KB; Ribeiro, RCL | 1 |
| Ashley, EA; Dahal, P; Guerin, P; Humphreys, GS; Mansoor, R; Stepniewska, K | 1 |
| Chounna Ndongmo, WP; Enyong, P; Esum, ME; Fombad, FF; Gandjui, NVT; Hoerauf, A; Kien, CA; Layland, LE; Njiokou, F; Njouendou, AJ; Pfarr, K; Ritter, M; Turner, J; Wanji, S | 1 |
| Adisa, BA; Oludele, OJ; Olufunso, OO | 1 |
| de Sena, LWP; Ferreira, MVD; Rivera, JGB; Vieira, JLF | 1 |
| Hastings, IM; Hodel, EM; Jones, S; Kay, K; Plucinski, M | 1 |
| Kim, S; Lek, D; Mairet-Khedim, M; Popovici, J; Roesch, C; Witkowski, B | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Carvalho, LJM; Nugraha, AB; Sivakumar, T; Tuvshintulga, B; Yokoyama, N | 1 |
| Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Boonprasert, K; Cheoymang, A; Kosa, N; Muhamad, P; Na-Bangchang, K | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Arango, D; Bottieau, E; Brosius, I; Burm, C; Cisse, B; De Hondt, A; Faye, BT; Mboup, S; Mbow, M; Paredis, L; Polman, K; Potters, I; Roucher, C; Smekens, B; Tsoumanis, A; van Herrewege, Y | 1 |
| Cui, L; Feng, R; Qian, J; Wang, B; Wang, M; Ye, C; Zhang, J; Zhang, M | 1 |
| Boechat, N; Campos Aguiar, AC; da Silva Araújo, M; Krettli, AU; Medeiros, JF; Penna-Coutinho, J; Pereira, DB; Rios, CT; Sá, PM | 1 |
| Amendoeira, FC; Boniatti, J; Calil-Elias, S; Carr, O; da Fonseca, LB; da S Teixeira, RG; Dantas, FML; de A V Gandos, T; Ferreira, IAM; Oliveira, KC; Oliveira, ON; Rios, LPS; Santana, AKM; Shimizu, FM; Tappin, MRR; Viçosa, AL | 1 |
| Chaoratanakawee, S; Chin, G; Harrison, D; Lek, D; Menard, D; Rachmat, A; Rogers, WO; Saunders, D | 1 |
| Barale, JC; Bouillon, A; Chy, S; Eam, R; Kauy, C; Ke, S; Khean, C; Khim, N; Kim, S; Kloeung, N; Kul, C; Leang, R; Mairet-Khedim, M; Ringwald, P; Roesch, C; Srun, S; Witkowski, B | 1 |
| Na-Bangchang, K; Saeheng, T | 1 |
24 review(s) available for mefloquine and artesunic acid
| Article | Year |
|---|---|
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Rural Health; Sesquiterpenes; Suppositories | 1997 |
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 1999 |
Combination therapy for malaria in Africa: hype or hope?
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Cross-Cultural Comparison; Half-Life; Humans; Insecticide Resistance; Malaria; Mefloquine; Pyrimethamine; Self Medication; Sesquiterpenes; Sulfadoxine; Thailand | 2000 |
[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthyridines; Plasmodium; Sesquiterpenes | 2000 |
Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Sesquiterpenes; Thailand | 2001 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 2005 |
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
The pharmacogenetics of antimalaria artemisinin combination therapy.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Genetic Markers; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Pharmacogenetics; Plasmodium falciparum; Polymorphism, Single Nucleotide | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Drugs for treating urinary schistosomiasis.
Topics: Adult; Anthelmintics; Artemisinins; Artesunate; Child; Humans; Mefloquine; Praziquantel; Randomized Controlled Trials as Topic; Schistosomiasis haematobia; Trichlorfon | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2019 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations | 2021 |
Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Child, Preschool; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Recurrence | 2022 |
101 trial(s) available for mefloquine and artesunic acid
| Article | Year |
|---|---|
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1992 |
Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Mefloquine; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Tetracycline | 1992 |
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome | 1995 |
Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand; Time Factors | 1994 |
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Recurrence; Sesquiterpenes | 1994 |
Artemisinin: large community studies.
Topics: Administration, Oral; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Prospective Studies; Sesquiterpenes; Suppositories | 1994 |
Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Pharmacokinetics of mefloquine alone or in combination with artesunate.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Cerebral; Male; Mefloquine; Middle Aged; Sesquiterpenes; Single-Blind Method; Suppositories; Thailand | 1997 |
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Packaging; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Patient Compliance; Sesquiterpenes | 1998 |
Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1999 |
A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Time Factors; Treatment Outcome | 1998 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women.
Topics: Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Female; Gestational Age; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Probability; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2001 |
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central Nervous System Diseases; Child; Double-Blind Method; Drug Administration Schedule; Drug Packaging; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome | 2002 |
Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Base Sequence; Cohort Studies; DNA, Protozoan; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Molecular Sequence Data; Mutation; Peru; Plasmodium falciparum; Predictive Value of Tests; Protozoan Proteins; Sequence Alignment; Sesquiterpenes | 2003 |
An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Sesquiterpenes; Thailand; Trimethoprim | 2002 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Primaquine; Secondary Prevention; Sesquiterpenes | 2003 |
[A randomized comparative study of naphtoquine, mefloquine and artsunate in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Ecuador; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2003 |
Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Rural Health; Sesquiterpenes | 2004 |
Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Bolivia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2003 |
Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome; Vietnam | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Thailand | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Sudan; Treatment Outcome | 2005 |
Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Pediatrics; Sesquiterpenes | 2005 |
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Time Factors; Treatment Outcome | 2005 |
Life-saving rectal artesunate for complicated malaria in children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Suppositories; Thailand; Treatment Outcome | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Quinolines; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy and safety of an artesunate/mefloquine combination, (artequin) in the treatment of uncomplicated P. falciparum malaria in Kenya.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Remission Induction; Sesquiterpenes | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quality Control; Sesquiterpenes; Tablets; Thailand; Treatment Outcome | 2006 |
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
Topics: Adolescent; Adult; Aged; Animals; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand | 2007 |
Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.
Topics: Administration, Oral; Administration, Rectal; Adolescent; Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Single-Blind Method; Treatment Outcome | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
An analytical method with a single extraction procedure and two separate high performance liquid chromatographic systems for the determination of artesunate, dihydroartemisinin and mefloquine in human plasma for application in clinical pharmacological stu
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Female; Freezing; Humans; Male; Mefloquine; Reproducibility of Results; Sesquiterpenes; Time Factors | 2007 |
Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Tablets | 2007 |
A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Quinolines; Sesquiterpenes | 2007 |
Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Thailand; Treatment Outcome | 2008 |
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Prospective Studies; Quinolines; Thailand; Treatment Outcome | 2008 |
Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Rural Population; Time Factors | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2009 |
Artemisinin resistance in Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Recurrence; Young Adult | 2009 |
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Asia; Asia, Southeastern; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nervous System Diseases; Neurologic Examination | 2009 |
Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria.
Topics: Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Hematocrit; Humans; Infant; Malaria, Falciparum; Mefloquine; Nigeria; Treatment Failure | 2009 |
[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Female; Fever; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Pilot Projects; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Topics: Abdominal Pain; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Parasite Egg Count; Plasmodium falciparum; Praziquantel; Schistosoma haematobium; Schistosomiasis haematobia; Treatment Outcome | 2010 |
Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Developing Countries; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine | 2010 |
Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Dosage Forms; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine | 2010 |
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Treatment Outcome; Young Adult | 2010 |
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Therapy, Combination; Fever; Humans; Ibuprofen; Injections, Intravenous; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2010 |
Use of area under the curve to evaluate the effects of antimalarial drugs on malaria-associated anemia after treatment.
Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum | 2011 |
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Young Adult | 2010 |
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum | 2010 |
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
Topics: Adolescent; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Male; Mefloquine; Opisthorchiasis; Opisthorchis; Parasite Egg Count; Phenylenediamines; Praziquantel; Treatment Outcome | 2011 |
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Quinolines; Young Adult | 2010 |
Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Epidemiologic Methods; Ethanolamines; Female; Fever; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Treatment Outcome | 2011 |
Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Torsades de Pointes; Young Adult | 2011 |
Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Audiometry; Child; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthyridines; Proportional Hazards Models; Young Adult | 2012 |
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2012 |
Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Base Sequence; Chemistry, Pharmaceutical; DNA, Protozoan; Drug Combinations; Female; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Parasite Load; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Senegal; Treatment Outcome; Young Adult | 2012 |
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Demography; Drug Therapy, Combination; Endemic Diseases; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2013 |
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Female; Humans; Malaria, Falciparum; Mefloquine; Plasma; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2014 |
Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
Topics: Adolescent; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Cote d'Ivoire; Drug Therapy, Combination; Female; Humans; Male; Mefloquine; Praziquantel; Schistosoma haematobium; Schistosomiasis haematobia | 2014 |
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Plasmodium knowlesi; Research Design; Severity of Illness Index | 2014 |
Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Female; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Monte Carlo Method; Plasma; Young Adult | 2015 |
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.
Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Birth Weight; Burkina Faso; Drug Combinations; Ethanolamines; Female; Fetal Development; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant, Newborn; Malaria; Malawi; Mefloquine; Placentation; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Quinolines; Zambia | 2015 |
Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Middle Aged; Plasmodium knowlesi; Young Adult | 2016 |
No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2016 |
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Vivax; Male; Mefloquine; Middle Aged; Plasmodium vivax; Treatment Outcome; Young Adult | 2016 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Mefloquine; Pregnancy; Quinolines; Recurrence; Risk; Treatment Outcome; Young Adult; Zambia | 2017 |
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Incidence; India; Intention to Treat Analysis; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Recurrence | 2019 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
Topics: Anthelmintics; Artesunate; Child; Humans; Mefloquine; Randomized Controlled Trials as Topic; Schistosomiasis; Senegal; Treatment Outcome | 2021 |
141 other study(ies) available for mefloquine and artesunic acid
| Article | Year |
|---|---|
Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Recurrence; Sesquiterpenes | 1992 |
[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1985 |
Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Suppositories; Time Factors; Treatment Outcome | 1995 |
Circulating L-selectin is elevated in patients with Plasmodium falciparum malaria.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Cell Adhesion Molecules; Humans; L-Selectin; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 1995 |
Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1993 |
Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Fibroblast Growth Factor 2; Humans; Kinetics; Laminin; Malaria, Falciparum; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes; Vietnam | 1997 |
Treatment of severe falciparum malaria with artesunate and mefloquine.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Retrospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Humans; Immunoassay; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Kinetics; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Pilot Projects; Plasmodium falciparum; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1999 |
Pulmonary edema in cerebral malaria patients in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; APACHE; Artemisinins; Artesunate; Drug Administration Schedule; Female; Humans; Intensive Care Units; Malaria, Cerebral; Male; Mefloquine; Middle Aged; Prognosis; Prospective Studies; Pulmonary Edema; Respiratory Distress Syndrome; Sesquiterpenes; Thailand | 1998 |
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1999 |
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Calcitonin; Calcitonin Gene-Related Peptide; Chemokine CCL4; Child; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Erythropoietin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nitrates; Plasmodium falciparum; Protein Precursors; Reference Values; Sesquiterpenes; Stem Cell Factor | 2000 |
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Audiometry; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Combinations; Female; Health Care Costs; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Patient Compliance; Rural Population; Sesquiterpenes | 1999 |
Antimalarial drug combination policy: a caveat.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Combinations; Drug Resistance; Endemic Diseases; Health Policy; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cohort Studies; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Random Allocation; Sesquiterpenes; Thailand | 2000 |
Fake antimalaria drugs in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Humans; Malaria; Mefloquine; Product Surveillance, Postmarketing; Sesquiterpenes | 2001 |
Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Models, Biological; Parasitemia; Plasmodium; Sesquiterpenes | 2002 |
Resistant malaria in a neonate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Quinine; Risk Assessment; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2002 |
Use of nested PCR for differential diagnosis of falciparum malaria reinfection and relapse in drug-resistant patients.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Artesunate; Diagnosis, Differential; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Recurrence; Sesquiterpenes; Time Factors | 2002 |
[Effect of pyronaridine, mefloquine and quinine on artesunate-sensitive and artesunate-resistant Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Synergism; Mefloquine; Naphthyridines; Plasmodium falciparum; Quinine; Sesquiterpenes | 2000 |
Drug-resistant malaria in Bangladesh: an in vitro assessment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bangladesh; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2003 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Artesunate combinations for malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2004 |
The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes | 2004 |
In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Statistics, Nonparametric | 2005 |
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
Topics: Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Cross-Sectional Studies; Drug Labeling; Fraud; Humans; Malaria; Mefloquine; Self Medication; Sesquiterpenes | 2004 |
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Data Interpretation, Statistical; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2004 |
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Primaquine; Regression Analysis; Sesquiterpenes; Thailand; Treatment Outcome | 2004 |
Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Dietary Fats; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Treatment Outcome | 2005 |
Successful treatment of imported cerebral malaria with artesunate-mefloquine combination therapy.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Cerebral; Mefloquine; Reticulocytes; Sesquiterpenes; Travel; Treatment Outcome | 2006 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Administration, Oral; Adolescent; Adult; Age Distribution; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Failure; Treatment Outcome | 2006 |
[Relapse of Plasmodium falciparum malaria in a patient treated with artesunate].
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Mefloquine; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Therapy, Combination; Early Diagnosis; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; National Health Programs; Parasitic Sensitivity Tests; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Refugees; Sesquiterpenes; Thailand; Tropical Climate | 2006 |
Artemisinin combination therapies.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child, Preschool; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Quinolines; Sesquiterpenes | 2006 |
Malaria. "One step forward, two steps back".
Topics: Animals; Antimalarials; Artemisinins; Artesunate; DNA, Bacterial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium malariae; Sesquiterpenes | 2006 |
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Male; Mefloquine; Middle Aged; Sesquiterpenes; Spectrophotometry, Ultraviolet | 2007 |
Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach.
Topics: Algorithms; Animals; Antimalarials; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Computer Simulation; Dose-Response Relationship, Drug; Drug Resistance; False Positive Reactions; Inhibitory Concentration 50; Mefloquine; Models, Biological; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes | 2007 |
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Sesquiterpenes | 2007 |
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Resistance; Ghana; Humans; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
Topics: Adult; Animals; Artemisinins; Artesunate; Blood; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Schizonts; Sesquiterpenes; Thailand; Trophozoites | 2008 |
New combined pill to treat malaria is launched.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Tablets | 2008 |
Lack of multiple copies of pfmdr1 gene in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic | 2008 |
Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cell Line; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Spectroscopy; Malaria; Malaria, Falciparum; Mefloquine; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2008 |
Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance, Multiple; Female; Gene Dosage; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Population Surveillance; Protozoan Proteins | 2008 |
Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Thailand | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Topics: Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cambodia; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Genetic Variation; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Survival Analysis; Thailand; Treatment Failure | 2009 |
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Retrospective Studies; Thailand; Treatment Outcome | 2009 |
Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand | 2009 |
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Gene Dosage; Genetic Markers; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2010 |
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.
Topics: Adolescent; Animals; Artemisinins; Artesunate; Blood; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies | 2009 |
Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance, Bacterial; Geographic Information Systems; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Quinine | 2010 |
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Malaria, Falciparum; Mefloquine; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum | 2010 |
Symmetrical peripheral gangrene in childhood falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Female; Gangrene; Humans; Malaria, Falciparum; Mefloquine; Primaquine | 2010 |
Early diagnosis and treatment of falciparum malaria in Cambodian trauma patients.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Cohort Studies; Early Diagnosis; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Prevalence; Risk Factors; Surgical Wound Infection; Wounds and Injuries | 2009 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mefloquine; Mice; Mice, Inbred Strains; Parasitic Diseases, Animal; Parasitic Sensitivity Tests; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica; Schistosomicides; Treatment Outcome | 2011 |
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mass Spectrometry; Mefloquine; Middle Aged; Myanmar; Plasma; Plasmodium falciparum; Thailand; Treatment Failure; Treatment Outcome; Young Adult | 2010 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Isothermal microcalorimetry to study drugs against Schistosoma mansoni.
Topics: Animals; Anthelmintics; Artemisinins; Artesunate; Calorimetry; Drug Evaluation, Preclinical; Humans; Mefloquine; Microscopy; Oxamniquine; Parasitic Sensitivity Tests; Praziquantel; Schistosoma mansoni | 2011 |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sex Factors; Thailand; Time Factors; Treatment Outcome; Young Adult | 2011 |
Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2011 |
High dose artesunate in combination with mefloquine: pharmacovigilance in the Venezuelan Amazon.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Diarrhea; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pharmacovigilance; Retrospective Studies; Venezuela; Vomiting; Young Adult | 2012 |
A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Black People; Chromatography, High Pressure Liquid; Drug Combinations; Drug Monitoring; Humans; Mefloquine; Reference Standards; Reproducibility of Results; Saliva; Sensitivity and Specificity; Verapamil | 2012 |
In vitro assessment of drug resistance in Plasmodium falciparum in five States of India.
Topics: Amodiaquine; Artemisinins; Artesunate; Biomarkers, Pharmacological; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; India; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins | 2012 |
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; Drug Combinations; Female; Hospitalization; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Retrospective Studies; Thailand; Time Factors; Treatment Outcome; Young Adult | 2012 |
Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epidemiological Monitoring; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2012 |
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Discovery; Ethanolamines; Fluorenes; Host-Pathogen Interactions; Humans; Malaria, Falciparum; Mefloquine; Models, Statistical; Plasmodium falciparum; Quinolines | 2012 |
Study on the developmental toxicity of combined artesunate and mefloquine antimalarial drugs on rats.
Topics: Abnormalities, Drug-Induced; Animals; Antimalarials; Artemisinins; Artesunate; Bone and Bones; Drug Combinations; Drug Interactions; Embryonic Development; Female; Fetal Development; Mefloquine; Pregnancy; Rats; Rats, Wistar; Teratogens; Viscera | 2012 |
[New combination therapy against malaria].
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug Combinations; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Mefloquine; Naphthyridines | 2012 |
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania | 2013 |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Erythrocytes; Flow Cytometry; High-Throughput Screening Assays; Hydroxamic Acids; Inhibitory Concentration 50; Mefloquine; Merozoites; Plasmodium falciparum; Quinine; Quinolines; Schizonts; Time Factors | 2013 |
Effects of the combined artesunate and mefloquine antimalarial drugs on rat embryos.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryo Loss; Embryo, Mammalian; Embryonic Development; Female; Maternal Exposure; Mefloquine; Pregnancy; Rats; Rats, Wistar | 2013 |
The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.
Topics: Antimalarials; Artemisinins; Artesunate; Brazil; Drug Combinations; Drug Discovery; History, 21st Century; Humans; India; International Cooperation; Mefloquine; Public-Private Sector Partnerships | 2013 |
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
Topics: Antimalarials; Artemisinins; Artesunate; Climate; Community Health Workers; Cross-Sectional Studies; Drug Resistance; Female; Geography; Hospitalization; Humans; Malaria; Mefloquine; Myanmar; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Rain; Reproducibility of Results; Temperature; Thailand; Transients and Migrants | 2013 |
Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Fluorenes; Lumefantrine; Mefloquine; Models, Statistical; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Protozoan Proteins | 2013 |
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Female; Gene Dosage; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2013 |
Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Combinations; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Young Adult | 2013 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chloroquine; Doxycycline; Drug Resistance, Neoplasm; Humans; Mefloquine; Primaquine; Verapamil; Vinblastine | 2013 |
Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Seasons; Thailand; Time Factors | 2014 |
Schizontemia as an indicator of severe malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Body Mass Index; Female; Hematologic Tests; Humans; Malaria, Falciparum; Male; Mefloquine; Schizonts; Severity of Illness Index | 2013 |
Factors associated with cerebral malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Body Mass Index; Case-Control Studies; Female; Humans; Malaria, Cerebral; Male; Mefloquine; Plasmodium falciparum; Retrospective Studies; Thailand | 2013 |
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Brazil; Chloroquine; DNA, Protozoan; Drug Resistance; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins | 2014 |
Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Brazil; Drug Combinations; Drug Discovery; Drug Industry; Global Health; Health Care Sector; Health Services Needs and Demand; Humans; Internationality; Inventions; Malaria; Mefloquine; Neglected Diseases; Patents as Topic; Social Justice | 2014 |
Bilateral subhyaloid haemorrhage in a conscious patient: a new spectrum of ocular involvement by Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Artesunate; Eye Hemorrhage; Female; Fundus Oculi; Humans; Malaria, Falciparum; Mefloquine; Patient Positioning; Plasmodium falciparum; Young Adult | 2014 |
Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Female; Humans; Malaria, Vivax; Mefloquine; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Stillbirth; Thailand | 2014 |
Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Therapy, Combination; Female; Gene Expression; Genotype; Glucuronosyltransferase; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Polymorphism, Genetic; Treatment Outcome; UDP-Glucuronosyltransferase 1A9 | 2014 |
Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Gene Dosage; Haplotypes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Thailand; Young Adult | 2014 |
Metabolite footprinting of Plasmodium falciparum following exposure to Garcinia mangostana Linn. crude extract.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Garcinia mangostana; Glucose; Inhibitory Concentration 50; Mefloquine; Metabolic Networks and Pathways; Plant Extracts; Plasmodium falciparum; Xanthones | 2014 |
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Colombia; Drug Resistance; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Quinine | 2014 |
Severe vivax malaria: a case report and a literature review.
Topics: Antimalarials; Artemisinins; Artesunate; Asian People; Diagnosis, Differential; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Severity of Illness Index; Young Adult | 2014 |
The in vitro antimalarial interaction of 9-hydroxycalabaxanthone and α-mangostin with mefloquine/artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Interactions; Humans; Inhibitory Concentration 50; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand; Xanthones | 2014 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults.
Topics: Adolescent; Adult; Anti-HIV Agents; Antimalarials; Artemisinins; Artesunate; Asian People; Cross-Over Studies; Drug Interactions; Female; Healthy Volunteers; Humans; Lopinavir; Male; Mefloquine; Middle Aged; Ritonavir; Young Adult | 2015 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Benzothiazoles; Child; Child, Preschool; Chloroquine; Diamines; Drug Resistance; Fluorometry; Humans; Inhibitory Concentration 50; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Staining and Labeling | 2015 |
Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.
Topics: Antimalarials; Artemisinins; Artesunate; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2016 |
Simultaneous quantification of artesunate and mefloquine in fixed-dose combination tablets by multivariate calibration with middle infrared spectroscopy and partial least squares regression.
Topics: Artemisinins; Artesunate; Least-Squares Analysis; Mefloquine; Multivariate Analysis; Spectrophotometry, Infrared; Tablets | 2016 |
The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Microbial; Drug Therapy, Combination; Endemic Diseases; Health Policy; Humans; Malaria; Malaria, Falciparum; Mefloquine | 2016 |
Rubber workers on the front lines.
Topics: Adolescent; Agricultural Workers' Diseases; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Combinations; Drug Substitution; Farmers; Hevea; Human Migration; Humans; Malaria, Falciparum; Male; Mefloquine; Mekong Valley; Rubber; Young Adult | 2016 |
Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar, Senegal.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Lumefantrine; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Quinine; Quinolines; Senegal; Ubiquitin-Protein Ligases | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Artesunate-mefloquine: a malaria treatment for African children?
Topics: Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Treatment Outcome | 2016 |
In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand; Young Adult | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Topics: Adolescent; Adult; Anorexia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Host-Parasite Interactions; Humans; Malaria; Male; Mefloquine; Nausea; Outcome Assessment, Health Care; Plasmodium falciparum; Plasmodium vivax; Psychotic Disorders; Pyrimethamine; Sulfadoxine; Thailand; Vomiting; Young Adult | 2017 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Challenges in a product development partnership: a malaria treatment case study.
Topics: Antimalarials; Artemisinins; Artesunate; Brazil; Drug Combinations; Drug Design; Health Services Accessibility; Health Services Needs and Demand; Humans; Interviews as Topic; Malaria; Mefloquine; Public-Private Sector Partnerships | 2017 |
Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Topics: Adoptive Transfer; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Erythrocytes; Female; Flow Cytometry; Malaria; Mefloquine; Mice; Mice, Inbred C57BL; Parasitemia; Phagocytes; Plasmodium berghei; Plasmodium yoelii | 2017 |
Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
Topics: Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Resistance; Hemeproteins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2017 |
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice.
Topics: Animals; Antimalarials; Artesunate; Blood; Disease Models, Animal; Fluorescence; Malaria; Mefloquine; Mice; Models, Theoretical; Organisms, Genetically Modified; Parasite Load; Parasitemia; Plasmodium berghei; Staining and Labeling | 2018 |
Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Thailand; Young Adult | 2018 |
Topics: Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2018 |
Absence of
Topics: Antimalarials; Artemether; Artesunate; Brazil; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Gene Expression; Genetic Markers; Genotyping Techniques; Humans; Kelch Repeat; Malaria, Falciparum; Mefloquine; Molecular Epidemiology; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2018 |
Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Young Adult | 2019 |
Safety assessment of MEFAS: an innovative hybrid salt of mefloquine and artesunate for malaria treatment.
Topics: Animals; Antimalarials; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Mefloquine; Mice | 2021 |
K13 propeller domain mutations and pfmdr1 amplification in isolates of Plasmodium falciparum collected from Thai-Myanmar border area in 2006-2010.
Topics: Antimalarials; Artesunate; Drug Combinations; Drug Resistance; Humans; Kelch Repeat; Mefloquine; Multidrug Resistance-Associated Proteins; Myanmar; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Sequence Analysis, DNA; Thailand | 2019 |
The effect of dose on the antimalarial efficacy of artesunate-mefloquine against
Topics: Antimalarials; Artesunate; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome | 2019 |
In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening.
Topics: Amodiaquine; Animals; Antimalarials; Antinematodal Agents; Area Under Curve; Artesunate; Cattle; Cell Line; Culture Media; Filaricides; Haplorhini; Ivermectin; Mansonella; Mefloquine; Microfilariae; Movement; Rifampin | 2019 |
Regulated rutin co-administration reverses mitochondrial-mediated apoptosis in Plasmodium berghei-infected mice.
Topics: Animals; Apoptosis; Artemisinins; Artesunate; Drug Therapy, Combination; Malaria, Falciparum; Male; Mefloquine; Mice; Mitochondria; Plasmodium berghei; Rutin | 2020 |
Association of Lipid Levels with Mefloquine and Carboxy-Mefloquine Concentrations in Patients with Uncomplicated Falciparum Malaria.
Topics: Adult; Antimalarials; Artesunate; Biotransformation; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Triglycerides | 2020 |
A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy.
Topics: Algorithms; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Computational Biology; Computer Simulation; Data Interpretation, Statistical; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Microsatellite Repeats; Plasmodium falciparum; Reinfection; Treatment Failure | 2020 |
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; DNA Copy Number Variations; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Pharmaceutical Preparations; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines | 2020 |
Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo.
Topics: Aminoquinolines; Animals; Antimalarials; Artesunate; Babesia bovis; Babesia microti; Babesiosis; Disease Models, Animal; Drug Combinations; In Vitro Techniques; Lumefantrine; Mefloquine; Methylene Blue; Mice; Mice, Inbred BALB C | 2020 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Association between ABCB1 Polymorphisms and Artesunate-Mefloquine Treatment Responses of Patients with Falciparum Malaria on the Thailand-Myanmar Border.
Topics: Adolescent; Adult; Antimalarials; Artesunate; ATP Binding Cassette Transporter, Subfamily B; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Polymorphism, Genetic; Thailand; Young Adult | 2021 |
Development and application of immunoassays for rapid quality control of the antimalarial drug combination artesunate-mefloquine.
Topics: Antimalarials; Artesunate; Drug Therapy, Combination; Immunoassay; Mefloquine; Quality Control | 2022 |
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax | 2021 |
In Vivo and In Vitro Taste Assessment of Artesunate-Mefloquine, Praziquantel, and Benznidazole Drugs for Neglected Tropical Diseases and Pediatric Patients.
Topics: Animals; Artesunate; Child; Humans; Mefloquine; Nitroimidazoles; Praziquantel; Rats; Tablets; Taste | 2021 |
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Quinolines | 2023 |
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 2023 |